Annukka M Tuiskula

An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort

Javier Santoyo-Lopez, C. Semple, C. Haley, 2019, Scientific Reports.

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients

V. Salomaa, A. Havulinna, M. Viitasalo, 2018, BMC Medical Genetics.

The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?

P. Schwartz, M. Viitasalo, E. Widén, 2018, International journal of cardiology.

Effects of beta-blockers on ventricular repolarization documented by 24-h electrocardiography in long-QT syndrome type 2.

M. Viitasalo, K. Kontula, A. Marjamaa, 2022, Heart rhythm.

Effects of b -blockers on ventricular repolarization documented by 24-hour electrocardiography in long QT syndrome type 2

M. Viitasalo, K. Kontula, A. Marjamaa, 2022 .

Is Symptomatic Long QT Syndrome Associated with Depression in Women and Men?

M. Hintsanen, T. Hintsa, L. Keltikangas-Järvinen, 2017, Journal of Genetic Counseling.

Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses.

Antti-Pekka Sarin, S. Stirdivant, R. Mohney, 2017, Pharmacogenomics.

Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation

M. Viitasalo, E. Widén, L. Toivonen, 2020, PloS one.